Safety and Efficacy Study of a New Treatment for Recurrent Symptoms of Oral Herpes Virus Infection

The purpose of this study is to determine if a new treatment is effective for the treatment of recurrent symptomatic oral herpes virus infections.

Lead sponsor: Beech Tree Labs, Inc.•4 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Related studies

COMPLETEDPhase 2

Evaluation of Cold Sore Treatments on Ultra Violet (UV) Induced Cold Sores

NCT01902303 · Oral Herpes Simplex

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 13, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE1/PHASE2

Enrollment171

Start dateJan 2011

Last updatedAug 13, 2013

Condition

Oral Herpes Simplex

Locations shown

University of Kentucky College of Dentistry/Center for Oral Health Research

Lexington, Kentucky

School of Dental Medicine, University at Buffalo

Buffalo, New York

Family Dentistry

Norwich, New York

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 13, 2013Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions